Colorectal cancer screening

Best Practice and Research: Clinical Gastroenterology

Volumn 21, Issue 6, 2007, Pages 1031-1048

  Winawer, Sidney J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

adenomas; barium enema; colonoscopy; colorectal cancer; CTC; occult blood; polyps; screening; sigmoidoscopy; stool DNA

Indexed keywords

AGING; ARTICLE; BARIUM ENEMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CASE CONTROL STUDY; CLINICAL TRIAL; COLON POLYPOSIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST EFFECTIVENESS ANALYSIS; COWDEN SYNDROME; DEVELOPED COUNTRY; DEVELOPING COUNTRY; FAMILIAL CANCER; FAMILIAL COLON POLYPOSIS; GASTROINTESTINAL ENDOSCOPY; GENETIC RISK; HIGH RISK POPULATION; HUMAN; JUVENILE POLYP; OCCULT BLOOD; PATHOPHYSIOLOGY; PEUTZ JEGHERS SYNDROME; POLYPECTOMY; SAFETY; SIGMOIDOSCOPY; COLORECTAL TUMOR; COST BENEFIT ANALYSIS; DISEASE COURSE; ECONOMICS; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; INCIDENCE; MASS SCREENING; METHODOLOGY; MORTALITY; PATIENT SELECTION; PEDIGREE; PRACTICE GUIDELINE; PREDICTION AND FORECASTING; REVIEW; RISK FACTOR;

BARIUM DERIVATIVE; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

BARIUM COMPOUNDS; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; CONTRAST MEDIA; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INCIDENCE; MASS SCREENING; OCCULT BLOOD; PATIENT SELECTION; PEDIGREE; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SIGMOIDOSCOPY;

EID: 36749056785     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2007.09.004     Document Type: Article

References (41)

1. In: Parkin D.M., Whelan S.L., Ferlay J., et al. (Eds). Cancer incidence in five continents Vol. VIII (2002), IARC Scientific Publications, No. 155 Lyon, IARC
2. Morson B.C. The polyp-cancer sequence in the large bowel. Proc R Soc Med 67 6 (1974 Jun) 451-457
3. Voglestein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 391 (1988) 525-532
4. Imperiale T.F., Wagner D.R., Lin C.Y.Y., et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343 (2000) 169-174
5. Lieberman D.A., and Weiss D.G. Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345 (2001) 555-560
6. Winawer S.J., Zauber A.G., Fletcher R.H., et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer the American Cancer Society. Gastroenterology 130 6 (2006) 1872-1885
7. Winawer S., Fletcher R., Rex D., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124 (2003) 544-560
8. Burt R., and Neklason D.W. Genetic testing for inherited colon cancer. Gastroenterology 128 (2005) 1696-1716
9. Fuchs C.S., Giovannucci E.L., Colditz G.A., Hunter D.J., Speizer F.E., and Willett W.C. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331 25 (1994) 1669-1674
10. Winawer S.J., Zauber A.G., Gerdes H., et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 334 2 (1996) 82-87
11. Regula J., Purinski M., Kraszewska E., et al. Colonoscopy in colorectal-cancer screening for detection of advance neoplasia. N Engl J Med 355 18 (2006) 1863-1872
12. O'Brien M.J., Winawer S.J., Zauber A.G., et al. Flat adenomas in the National Polyp Study (NPS) ate not associated with an increased risk of high-grade initially nor during surveillance. Clin Gastroenterol Hepatol 2 10 (2004) 905-911
13. Jass J.R., Whitehall V.L., Young J., et al. Emerging concepts in colorectal neoplasia. Gastroenterology 123 (2002) 862-876
14. Huang C.S., O'Brien M.J., Yang S., et al. Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway. Am J Gastroenterol 99 (2004) 2242-2255
15. Burt R., and Jass J.R. Hyperplastic polyposis. In: Hamilton S.R., and Aaltonen L.A. (Eds). Pathology and genetics of tumours of the digestive system (2000), IARC Press, Lyon 135-136
16. Mandel J.S., Church T.R., Ederer F., and Bond J.H. Colorectal cancer mortality: effectiveness of biennial screening of fecal occult blood. J Natl Cancer Inst 91 5 (1999) 434-437
17. Faivre J., Dancourt V., Lejenune C., et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 126 7 (2004) 1674-1680
18. Kronborg O., Jorgensen O.D., Fenger C., and Rasmussen M. Randomized study of biennial screening with a fecal occult blood test: results after nine screening rounds. Scan J Gastroenterol 39 9 (2004) 846-851
19. Scholefield J.H., Moss S., Sufi F., Mangham C.M., and Hardcastle J.D. Effect of fecal occult blood screening on mortality from colorectal cancer: results from a randomized controlled trial. Gut 50 6 (2002) 840-844
20. Hewitson P., Glasziou P., Irwig L., et al. Screening for colorectal cancer using the fecal occult blood test, Hemoccult (Review). Cochrane Library (2007) Issue 1
21. Kewenter J., Brevinge H., Engaras B., Haglind E., and Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 29 5 (1994) 468-473
22. Young G.P., St. John D.J., Winawer S.J., et al. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 97 (2002) 2499-2507
23. Imperiale T.F., Ransohoff D.F., Itzkowitz S.H., Turnbull B.A., and Ross M.E. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351 26 (2004) 2704-2714
24. Itzkowitz S.H., Jandorf L., Brand R., et al. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 5 1 (2007) 111-117
25. Selby J.V., Friedman G.D., Quisenberry C.P., et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326 (1992) 653-657
26. Muller A.D., and Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 123 12 (1995) 904-910
27. Newcomb P.A., Norfleet R.G., Storer B.E., Surawicz T.S., and Marcus P.M. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84 20 (1992) 1572-1575
28. Rex D.K., Cutler C.S., Lemmel G.T., et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 112 (1997) 24-28
29. Pickhardt P.J., Choi J.R., Hwang I., et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349 (2003) 2191-2200
30. Winawer S.J., Zauber A.J., Ho M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. NEJM 329 (1993) 1977-1981
31. Brenner H., Arndt V., Sturner T., Stegmaier C., Ziegler H., and Dhom G. Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer 85 (2001) 972-976
32. Thiis-Evensen E., Hoff G.S., Sauer J., et al. Population based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Scand J Gastroenterol 34 (1999) 414-420
33. Barclay R.L., Vicari J.J., Doughty A.S., Johanson J.F., and Greenlaw R.L. Adenoma detection rates and colonoscopic withdrawal times during screening colonoscopy. NEJM 355 (2006) 2533-2541
34. Cotton P.B., Durkalski V.L., Pineau B.C., et al. Computer tomographic colonography (virtual colonoscopy): a multicentre comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 291 (2004) 1713-1719
35. Innacocone R., Laghi A., Catalano C., et al. Computed tomographic colonoscopy without cathartic preparation for the detection of colorectal polyps. Gastroenterology 127 (2004) 1300-1311
36. Rockey D.C., Paulson E., Niedzwiecki D., et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet 365 (2005) 305-311
37. Frazier A.L., Colditz G.A., Fuchs C.S., and Kuntz K.M. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 284 15 (2000) 1954-1961
38. Helm J.F., Russo M.W., Biddle A.K., Simpson K.N., Ransohoff D.F., and Sandler R.S. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing. Am J Gastroenterol 95 11 (2000) 3250-3258
39. Loeve F., Brown M.L., Boer R., van Ballegooijen M., van Oortmarssen G.J., and Habbema J.D. Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst 92 (2000) 557-563
40. Sonnenberg A., Delco F., and Inadomi J.M. Cost-Effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133 8 (2000) 573-584
41. Lieberman D. Cost-effectiveness of colonoscopy in screening for colorectal cancer; cost-effectiveness of screening colorectal cancer in the general population. Gastrointest Endosc 54 4 (2001) 537-538